Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

sector performance

Global Health/Biotechnology
View full league table

Total Return

Month by Month Performance

Quarterly Performance

to 29/09/2017 Annual Q1 Q2 Q3 Q4
2017 6.8% 5.1% 0.8%
2016 -16.3% -11.6% 4.5% -0.3% -9.0%
2015 8.2% 10.7% 4.0% -11.4% 6.1%
2014 23.8% 8.4% 6.5% 3.6% 3.6%
2013 41.4% 12.7% 4.0% 7.4% 12.3%
2012 14.3% 6.6% 2.3% 6.1% -1.3%
2011 13.7% 6.7% 7.4% -10.7% 11.2%
2010 16.4% 6.0% -8.5% 12.5% 6.6%
2009 25.4% -4.1% 6.8% 11.4% 10.0%
2008 -22.7% -14.7% 1.1% -1.3% -9.2%
2007 13.4% 1.5% 9.0% 0.5% 2.0%
2006 12.5% 7.0% -2.0% 6.1% 1.2%
2005 9.8% -7.2% 5.5% 10.1% 1.9%
2004 3.3% 0.8% 1.4% -6.9% 8.6%
2003 20.3% -1.0% 16.5% -0.5% 4.8%
2002 -23.4% -3.1% -12.8% -17.1% 9.3%
2001 0.4% -2.9%

Returns Vs Risk

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in USD).

Registered For Sale In

  1. United States

Fund Info

  • Launch date18/06/2001
  • Share Class size893Mn
  • Base currencyUSD
  • ISINUS3163904424

Purchase Info

  • Min. initial investment2,500
  • Min. regular additional investment0

Charges

  • Annual management0.55%
  • Initial investment0